Pathogenesis of familial acromegaly

Frontiers of Hormone Research

Volumn 38, Issue , 2010, Pages 121-126

  Gadelha, Mônica R ^a,b   Frohman, Lawrence A ^c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione   (Brazil)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR;

ACROMEGALY; CANCER DIAGNOSIS; CHROMOSOME 11Q; CHROMOSOME 11Q13; CLINICAL FEATURE; DISEASE COURSE; FAMILIAL DISEASE; GENE MUTATION; GENETIC LINKAGE; GROWTH HORMONE SECRETING ADENOMA; HETEROZYGOSITY LOSS; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ACROMEGALY; CHROMOSOMES, HUMAN, PAIR 11; HUMAN GROWTH HORMONE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LOSS OF HETEROZYGOSITY; MUTATION;

EID: 84926083849     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000318501     Document Type: Review

References (20)

1. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R: Epidemiology of acromegaly in Newcastle region. Clin Endocrinol (Oxf) 1980;12: 71-79.
2. Etxabe J, Gaztambide P, Latorre P, Vasquez JA: Acromegaly: an epidemiological study. J Endocrinol Invest 1993;16:181-187.
3. Gadelha MR, Kineman RD, Frohman LA: Familial somatotropinomas: clinical and genetic aspects. Endocrinologist 1999;9:277-285.
4. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA: Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000;26: 89-92.
5. Stratakis CA, Carney JA, Lin J P, Papanicolaou DA, Karl M, Kastner DL, Pras E, Chrousos GP: Carney complex, a familial multiple neoplasia and lentigi-nosis syndrome: analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 2006;97:699-705.
6. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J, Atkinson MJ: Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 2006; 103:15558-15563.
7. Owens M, Stals K, Ellard S, Vaidya B: Germline mutations in the CDKN1B gene encoding p27Kip1 are a rare cause of multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 2009;70:499-500.
8. Igreja S, Chahal HS, Akker SA, Gueorguiev M, Popovic V, Damjanovic S, Wass JA, Quinton R, Grossman AB, Korbonits M: Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and AIP (aryl hydrocarbon receptor-interacting protein) genes in MEN1 syndrome patients without any detectable MEN1 gene mutations. Clin Endocrinol (Oxf) 2009;70:259-264.
9. Gadelha MR, Prezant TR, Une KN, Glick R P, Moskal SF, Vaisman M, Melmed S, Kineman RD, Frohman LA: Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene. J Clin Endocrinol Metab 1999;84:249-256.
10. Daly A F, Jaffrain-Rea ML, Ciccarelli A, et al: Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 2006;91:3316-3323.
11. Daly AF, Vanbellinghen JF, Khoo SK, et al: Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 2007;92:1891-1896.
12. Leontiou CA, Gueorguiev M, van der SJ, et al: The role of the AIP gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 2008;93: 2390-2401.
13. Georgitsi M, Heliovaara E, Paschke R, et al: Large Genomic Deletions in AIP in Pituitary Adenoma Predisposition. J Clin Endocrinol Metab 2008;93: 4146-4151.
14. Yamada S, Yoshimoto K, Sano T, Takada K, Itakura M, Usui M, Teramoto A: Inactivation of the tumor suppressor gene on 11q13 in brothers with familial acrogigantism without multiple endocrine neopla-sia type 1. J Clin Endocrinol Metab 1997;82:239-242.
15. Gadelha MR, Une KN, Rohde K, Vaisman M, Kineman RD, Frohman LA: Isolated familial soma-totropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12. J Clin Endocrinol Metab 2000;85:707-714.
16. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De ME, Makinen MJ, Launonen V, Karhu A, Aaltonen LA: Pituitary adenoma predisposition caused by ger-mline mutations in the AIP gene. Science 2006;312: 1228-1230.
17. Carver LA, Bradfield CA: Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J Biol Chem 1997; 272:11452-11456.
18. Bolger GB, Peden AH, Steele MR, MacKenzie C, McEwan DG, Wallace DA, Huston E, Baillie GS, Houslay MD: Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. J Biol Chem 2003;278:33351-33363.
19. Donangelo I, Gadelha M: Bases moleculares dos adenomas hipofisários com ênfase nos somatotro-pinomas. Arq Bras Endocrinol Metab 2004;48:464-479.
20. Taboada GF, Tabet ALO, Naves LA, Carvalho D P, Gadelha MR: Prevalence of gsp oncogene in soma-totropinomas and clinically non-functioning pituitary adenomas: our experience. Pituitary 2009;12: 165-169.